• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The molecular mechanism of te pathogenesis induced by Helicbacter phylori (TN2) and the clinical application

Research Project

Project/Area Number 11557040
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Gastroenterology
Research InstitutionThe University of Tokyo

Principal Investigator

OMATA Masao  Faculty of Medicin, The University of Tokyo, PROFESSOR, 医学部附属病院, 教授 (90125914)

Co-Investigator(Kenkyū-buntansha) YOSHIDA Haruhiko  Faculty of Medicin, The University of Tokyo, ASSISTANT, 医学部附属病院, 助手 (60240305)
NAKAO Masafumi  Takeda Chemical Industries, SCIENTIST, 創薬研究本部, 首席研究員
Project Period (FY) 1999 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥12,800,000 (Direct Cost: ¥12,800,000)
Fiscal Year 2001: ¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2000: ¥4,700,000 (Direct Cost: ¥4,700,000)
Fiscal Year 1999: ¥4,700,000 (Direct Cost: ¥4,700,000)
KeywordsHelicobacter pylori / intracellular signaling pathways / cagPAI / Mongolian gerbil infection model / microarray / CagA / cagPAI / CagPAI / マイクロアレイ / 胃炎 / リン酸化
Research Abstract

(1) NF-kB activation by H. pylori
We analyzed the molecular mechanism of H. pylori-mediated NF-kB activation in both a gastric epithelial cell line and in a monocytic cell line.
In gastric cancer cells, H. pylori possessing intact cag PAI activates NF-kB through a signaling pathway involving IkB kinases (IKK's), NF-kB-inducing kinase (NIK), TRAF2, and TRAF6. In a monocytic cell line, H. pylori-mediated NF-kB activation involves TLR4 but is independent of cag PAI.
(2) The activation of ERK/MARK cascade by H. pylori
H. pylori with intact cage PAI activated SRE, c-fos and Cyclin D1 transcription through the activation of ERK/MAPK cascade in human gastric cancer cells.
(3) SRE activation by CagA protein
It has been reported that CagA protein is translocated into epithelial cells and associated with cellular cytoskeletal rearrangements. We identified a new role of CagA protein as an activator of SRE.
(4) cDNA microarray analysis of H. pylori-mediated alteration of gene expression
We compared mRNA profiles in human gastric cancer cells with and without H. pylori cocultured by using an in-house cDNA microarray. Coculture with cag PAI positive strain significantly up-regulated mRNA expression in 8 of 2304 genes fested.
(5) Mongolian gerbil infection model
We examined the role of cag PAI in the gastric pathogenesis induced by H. pylori using a long-term (62 wk) animal model. Mongolian gerbils were challenged with TN2 and its isogenic mutants of cagE or vacA. No ulcer was found in the gerbils infected with the cagE mutant, and cagE mutants induced only mild gastritis cag PAI plays an essential role in the pathogenesis of gastric diseases related H. pylori infection.
Furthermore, we validated a 3-week gerbil model using isogenic mutants for screening of proinflammatory virulence determinants of H. pylori in vivo.

Report

(4 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • 1999 Annual Research Report
  • Research Products

    (57 results)

All Other

All Publications (57 results)

  • [Publications] Maeda S, et al.: "Detection of clarithromycin-resistant Helicobacter pylori strains with a preferential homo-duplex formation assay"J Clin Microbiol. 38. 210-214 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Asahi M, et al.: "Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells"J Exp Med. 191. 593-602 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshida H, et al.: "Determination of the optimal cut-off value for [13C]urea breath test based on a Helicobacter pylori-specific PCR assay"J Gastroenterol Hepatol. 15. 155-160 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, et al.: "Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used -CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs"Cancer. 88. 1530-1535 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, et al.: "H. pylori activates NF-kappa B through a signaling pathway involving I kappa B kinases, NF-kappa B-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells"Gastroenterology. 119. 97-108 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ogura K, et al.: "Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil"J Exp Med. 192. 1601-1610 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ikenoue T, et al.: "Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island"Clin Diagn Lab Immunol. 8. 181-186 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Matsumura M, et al.: "Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium"J Clin Microbiol. 39. 691-695 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Hirata Y, et al.: "Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells"Infect Immun. 69. 3965-3971 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, et al.: "cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells"Biochem Biophys Res Commun. 284. 443-449 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mitsuno Y, et al.: "Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells"Gut. 49. 18-22 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ogura K, et al.: "Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection : How long should it be given?"Scand J Gastroenterol. 36. 584-588 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamaji Y, et al.: "Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer : analysis of 5732 Japanese subjects"Gut. 49. 335-340 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, et al.: "Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells"J Biol Chem. 276. 44856-44864 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Akanuma M, et al.: "The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease using short-term Mongolian gerbil infection model"J Infect Dis. 185. 341-347 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamaji Y, et al.: "Weak response of Helicobacter pylori antibody is high risk for gastric cancer : a cross-sectional study of 10,234 endoscoped Japanese"Scand J Gastroenterol. 37. 148-153 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mitsuno Y, et al.: "Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation"Biochem Biophys Res Commun. 291(in press). 868-874 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, Yoshida H, Matswunaga H, Ogura K, Kawamata O, Shiratori Y, Omata M: "Detection of clarithromycin-resistant Helicobacter pylori strains with a preferential homo-duplex formation assay"J. Cloin Microbiol. 38. 210-214 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Asahi M, Azuma T, Ito S,m Ito Y,m Suto H,m Nagai Y,m Tsubokawa M, Tohyama Y, Maeda S, Omata M, Suzuki T, and Sasakawa C: "Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells"J Exp Med.. 191. 593-602 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshida H, Hirota K, Ogura K, Maeda S, Shiratori Y, Sasaki Y, Omata M: "Determination of the optimal cut-off value for [13C]urea breath test based on a Helicobacter pylori-specific PCR assay"J. gastroenterol Hepatol. 15. 155-160 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, Yoshida H. Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K,m Mafune K, Kawabe T, Shiratori Y, Omata M: "Assessment of gastric carcinoma risk associated with helicobactoer pylori may vary depending on the antigen used - CagA specific enzyme-linked immunoadsorbevnt assay (ELISA) versus commercially available H. pylori ELISAs"Cancer. 88. 1530-1535 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y, Akanuma M, Shiratori Y, Omata M: "H. pylori activates NF-kappa B through a signaling pathway involving I kappa B kinases, NF-kappa B-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells"Gastroenterology. 119. 97-108 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku T, Yoshida H, Shiratori Y, Omata M: "Virulence factors of Helicobacter pylort responsible for gastric diseases in Mongolian gerbil"J Exp Med.. 192. 1601-1610 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshida H, Shiratori Y, Omata M: "Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island"Clin diagn Lab Immunolo.. 8. 181-186 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Matsumura M, Hikiba Y, Ogura K, Togo G, Tsukuba I, Ushikawa K, Shiratori Y, Omata M: "Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium"J Clin Microbiol.. 39. 691-695 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Hirata Y, Maeda S, Mitsuno Y, Akanuma M, Yamaji Y, Ogura K, Yoshida H, Shiratori Y, Omata M: "Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells"Infect Immun.. 69. 3965-3971 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, Otsuka M, Hirata Y, Mitsuno Y, Yoshida H, Shiratori Y, Masuho Y, Muramatsu M, Seki N, Omata M: "cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells"Biochem Biophys Res Commun.. 284. 443-449 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mitsuno Y, Yoshida H, Maeda S, Ogura K, Hirata Y, Kawabe T, Shiratori Y, Omata M: "Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells"Gut. 49. 18-22 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ogura K, Yoshida H, Maeda S, Yamaji Y, Kawabe T, Okamoto M, Shiratori Y, Omata M: "Clarithromycin-based triple therapy for non-resistant helicobacter pylori infection : How long should it be given?"Scand J Gastroenterol.. 36. 584-588 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M: "Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer : analysis of 5732 Japanese subjects"Gut. 49. 335-340 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H, Shiratori Y, Omata M: "Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells"J Biol Chem.. 276. 44856-44864 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Akanuma M, Maeda S, Ogura K, Mitsuno Y, Hirata Y, Ikenoue T, Otsuka M, Watanabe T, Yamaji Y, Yoshida H, Kawabe T, Shiratori Y, Omata M: "The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease using short-term Mongolian gerbil infection model"J. Infect Dis.. 185. 341-347 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M: "Weak response of Helicobacter pylori antibody is high risk for gastric cancer : a cross-sectional study of 10,234 endoscoped Japanese"Scand J Gastroenterol.. 37. 148-153 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mitsuno Y, Maeda S, Yoshida H, Hirata Y, Ogura K, Akanumka M, Kawabe T, Shiratori Y, Omata M: "Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation"Biochem Biophys Res Commun.. 291(in press). 868-874 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maeda S, et al.: "Detection of clarithromycin-resistant Helicobacter pylori strains with a preferential homo-duplex formation assay"J Clin Microbiol. 38. 210-214 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Asahi M, et al.: "Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells"J Exp Med. 191. 593-602 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yoshida H, et al.: "Determination of the optimal cut-off value for [13C]urea breath test based on a Helicobacter pylori-specific PCR assay"J Gastroenterol Hepatol. 15. 155-160 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Maeda S, et al.: "Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used - CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs"Cancer. 88. 1530-1535 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Maeda S, et al.: "H. pylori activates NF-kappa B through a signaling pathway involving I kappa B kinases, NF-kappa B-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells"Gastroenterology. 119. 97-108 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ogura K, et al.: "Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil"J Exp Med. 192. 1601-1610 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ikenoue T, et al.: "Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island"Clin Diagn Lab Immunol. 8. 181-186 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Matsumura M, et al.: "Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium"J Clin Microbiol. 39. 691-695 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hirata Y, et al.: "Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells"Infect Immun. 69. 3965-3971 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Maeda S, et al.: "cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells"Biochem Biophys Res Commun. 284. 443-449 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Mitsuno Y, et al.: "Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells"Gut. 49. 18-22 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ogura K, et al.: "Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection : How long should it be given ?"Scand J Gastroenterol. 36. 584-588 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamaji Y, et al.: "Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer : analysis of 5732 Japanese subjects"Gut. 49. 335-340 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Maeda S, et al.: "Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells"J Biol Chem. 276. 44856-44864 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Akanuma M, et al.: "The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease using short-term Mongolian gerbil infection model"J Infect Dis. 185. 341-347 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamaji Y, et al.: "Weak response of Helicobacter pylori antibody is high risk for gastric cancer : a cross-sectional study of 10,234 endoscoped Japanese"Scand J Gastroenterol. 37. 148-153 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Mitsuno Y, et al.: "Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation"Biochem Biophys Res Commun. 291(in press). 868-874 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ogura K, et al: "Virulence Factors of Helicobacter pylori Responsible for Gastric Diseases in Mongolian Gerbil"J Exp Med. 192. 1601-1610 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Maeda S, et al: "H. pylori Activates NF-αB Through a Signaling Pathway Involving IB Kinases, NF-B-Inducing Kinase, TRAF2, and TRAF6 in Gastric Cancer Cells"Gastroenterology. 119. 97-108 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ikenoue T, et al: "Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island."Clin Diagn Lab Immunol. 8. 181-186 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Maeda S: "Detection of clarithromycin-resistant Helicobacter pylori strains by a preferential homoduplex formation assay"Journal of Clinical Microbiology. 38. 210-214 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Asahi M: "Helicobacter pylori Cag A protein can be tyrosine phosphorylated in gastric epithelial cells"Journal of Cell Biology. 191. 593-602 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Maeda S: "Risk assessment of gastric cancer and Helicobacter pylori may vary depending upon the antigen used : Cag A specific ELISA versus canmercially available H pylori ELISA's"Cancer. (in press). (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi